Mesalamine FDA Link Generic

An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)

Also Known As:

Mesalazine; Canasa; Pentasa; Rowasa; 5 Aminosalicylic Acid; 5-Aminosalicylic Acid; Asacol; Asacolon; Ascolitin; Claversal; Fivasa; Lixacol; Mesalamine Hydrochloride; Mesalamine Monosodium Salt; Mesasal; Novo-5 ASA; Salofalk; m-Aminosalicylic Acid; meta-Aminosalicylic Acid; 5 Aminosalicylate; Hydrochloride, Mesalamine; Monosodium Salt, Mesalamine; Novo 5 ASA; m Aminosalicylic Acid; meta Aminosalicylic Acid; 5-Aminosalicylate

Pharmalogical Action Categories:

Anti-Inflammatory Agents, Non-Steroidal

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Benzene Derivatives: 17
        Phenols: 677
        Hydroxybenzoates: 18
        Salicylates: 2339
        Aminosalicylic Acids: 5
        Mesalamine: 2709
        Benzoates: 426
        Hydroxybenzoates: 18
        Salicylates: 2339
        Aminosalicylic Acids: 5
        Mesalamine: 2709
        Aminobenzoates: 1
        meta-Aminobenzoates
        Mesalamine: 2709
- Carboxylic Acids: 973
  - Hydroxy Acids: 94
    - Hydroxybenzoates: 18
      - Salicylates: 2339
        Aminosalicylic Acids: 5
        Mesalamine: 2709
  - Carbocyclic Acids
    - Benzoates: 426
      - Hydroxybenzoates: 18
        Salicylates: 2339
        Aminosalicylic Acids: 5
        Mesalamine: 2709
      - Aminobenzoates: 1
        meta-Aminobenzoates
        Mesalamine: 2709

Maria Juliana Serrano Nieto Selected Research

Maria Juliana Serrano Nieto Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure